Differential regulation of cell proliferation and protease secretion by epidermal growth factor and amphiregulin in tumoral versus normal breast epithelial cells

British Journal of Cancer

Volumn 84, Issue 7, 2001, Pages 936-945

  Silvy, M ^a   Giusti, C ^a   Martin, P M ^a   Berthois, Y ^a  

^a AIX MARSEILLE UNIVERSITY   (France)

Author keywords

Amphiregulin; Breast cancer cells; Epidermal growth factor; Proteases

Indexed keywords

AMPHIREGULIN; EPIDERMAL GROWTH FACTOR; MATRIGEL; MESSENGER RNA; PLASMINOGEN ACTIVATOR; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTEINASE; UROKINASE;

ARTICLE; BREAST CANCER; BREAST EPITHELIUM; CELL PROLIFERATION; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; PRIORITY JOURNAL; PROTEIN SECRETION; TUMOR CELL CULTURE;

ADENOCARCINOMA; ADOLESCENT; ADULT; BREAST; BREAST NEOPLASMS; CELL DIVISION; CELLS, CULTURED; EPIDERMAL GROWTH FACTOR; EPITHELIAL CELLS; FEMALE; GENE EXPRESSION REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GLYCOPROTEINS; GROWTH SUBSTANCES; HUMANS; IMMUNOPHENOTYPING; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; NEOPLASM INVASIVENESS; PLASMINOGEN ACTIVATOR INHIBITOR 1; TUMOR CELLS, CULTURED; URINARY PLASMINOGEN ACTIVATOR;

EID: 0035815249     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1054/bjoc.2000.1678     Document Type: Article

References (33)

1. The urokinase-type plasminogen activator system in cancer metastasis: A review
2. Prognosis value of urokinase-type plasminogen activator (uPA) and plasminogen activator inhibitors PAI-1 and PAI-2 in breast carcinomas
3. Transforming growth factor α (TGFα) mRNA expression in human breast carcinomas and TGFα activity in the effusions of breast cancer patients
4. Technique for radiolabelling DNA restriction endonuclease fragments to high specific activity
5. Prognostic value of urokinase-type plasminogen activator in 671 primary breast cancer patients
6. Evaluation of epidermal growth factor-related growth factors and receptors and of neoangiogenesis in completely resected stage 1-IIIA non-small-cell lung cancer: Amphiregulin and microvessel count are independent prognosis indicators of survival
7. Context-dependent transcriptional regulation
8. A heparin-binding growth factor secreted by macrophage-like cells that is related to EGF
9. Autocrine action of amphiregulin in a colon carcinoma cell line and immunocytochemical localization of amphiregulin in human colon
10. crbB2. Evidence that amphiregulin acts exclusively through the epidermal growth factor receptor at the surface of human epithelial cells
11. Characterization of high and low molecular forms of amphiregulin that differ in glycosylation and peptide core length
12. Transforming growth factor α (TGFα) and amphiregulin (AR) as autocrine growth factors in nontransformed, immortalized 184A1N4 human mammary epithelial cells
13. Detection and location of amphiregulin and Cripto-1 expression in the developing postnatal mouse mammary gland
14. Induction of ductal morphogenesis and lobular hyperplasia by amphiregulin in the mouse mammary gland
15. Epidermal growth factor an amphiregulin up-regulate matrix metalloproteinase-9 (MMP-9) in human breast cancer cells
16. Amphiregulin, epidermal growth factor receptor, and estrogen receptor expression in human primary breast cancer
17. Heparin inhibition of autonomous growth implicates amphiregulin as an autocrine growth factor for normal human mammary epithelial cells
18. Antisense expression for amphiregulin suppresses tumorigenicity of a transformed human breast epithelial cell line
19. Estrogen and phorbol esters regulate amphiregulin expression by two separate mechanisms in human breast cancer cell lines
20. Epidermal growth factor-related peptides in the pathogenesis of human breast cancer
21. Amphiregulin as an autocrine growth factor for c-Ha-ras and c-erbB-2-transformed human mammary epithelial cells
22. Amphiregulin anti-sense oligodeoxynucleotides inhibit growth and transformation of a human colon carcinoma cell line
23. Differential immunohistochemical detection of transforming growth factor α, amphiregulin and cripto in human normal and malignant breast tissues
24. Expression of transforming growth factor α, amphiregulin and cripto-1 in human breast carcinomas
25. The epidermal growth factor receptor couples transforming growth factor-α, heparin-binding epidermal growth factor-like factor, and ampbiregulin to Neu, ErbB-3, and ErbB-4
26. Role of the plasminogen activator and matrix metalloproteinase systems in epidermal growth factor- and scatter factor-stimulated invasion of carcinoma cells
27. The role of amphiregulin in breast cancer
28. Epidermal growth factor receptor-dependent stimulation of amphiregulin expression in androgen-stimulated human prostate cancer cells
29. Amphiregulin: A bifunctional growth-modulating glycoprotein produced by the phorbol 12-myristate 13-acetate-treated human breast adenocarcinoma cell line MCF-7
30. Differential dose-dependent effects of epidermal growth factor on gene expression in A431 cells: Evidence for a signal transduction pathway that can bypass Raf-1 activation
31. FGF2 as an autocrine growth factor for immortal human breast epithelial cells
32. EGF induces the expression of matrilysin in the human prostate adenocarcinoma cell line LNCaP
33. Clinicopathological analysis of amphiregulin and heregulin immunostaining in breast neoplasia